Welcome to Labeled Immunoassays and Clinical Medicine website!
Orignal Article

Clinical Significance of Changes of Serum 8-iso-PGF, SOD andMDA Levels in Patients with Hypertension

  • LIU Ning ,
  • SUN An-ping ,
  • WANG Jin-song ,
  • LIU Jing ,
  • JIANG Chu-tao ,
  • Xiao Jun ,
  • LUO Rong ,
  • JIN Wen-ping ,
  • YU Xin- zhi ,
  • WANG Jun-jun ,
  • ZHOU Hong
Expand
  • Department of Laboratory Medicine, Wuhan Xinzhou People′s Hospital, Wuhan 430400, China

Received date: 2012-11-19

  Online published: 2013-08-20

Abstract

Objective To explore the changes of serum 8-iso-PGF,superoxide dismutase (SOD) and malondialdehyde(MDA) levels in patients with essential hypertension.Methods The content of 8-iso-PGF, SOD and MDA levels in 193 cases of essential hypertension and 52 controls were detected by using ELESA, xanthine oxidase and thiobarbituric acid method. Results The serum 8-iso-PGF levels in patients were obviously higher than those in controls (P<0.05), the SOD levels were significantly lower than those in controls (P<0.01) and the MDA levels were significantly higher than those in controls (P<0.01). When the blood pressure increased, the content of SOD was decreased, and there was a significantly negative correlation (r=-0.74). But to the 8-iso-PGF and MDA, when the blood pressure increased the content of them was increased,There was a significantly positive correlation between the blood pressure with 8-iso-PGF and MDA levels respectively (r=0.62, r=0.81). Conclusion The levels of serum 8-iso-PGF, SOD and MDA are closely correlated to the severity of hypertension, and they may be used for evaluation of patients with hypertension.

Cite this article

LIU Ning , SUN An-ping , WANG Jin-song , LIU Jing , JIANG Chu-tao , Xiao Jun , LUO Rong , JIN Wen-ping , YU Xin- zhi , WANG Jun-jun , ZHOU Hong . Clinical Significance of Changes of Serum 8-iso-PGF, SOD andMDA Levels in Patients with Hypertension[J]. Labeled Immunoassays and Clinical Medicine, 2013 , 20(1) : 7 -10 . DOI: 10.11748/bjmy.issn.1006-1703.2013.01.003

References

[1] 刘力生.2004年中国高血压防治指南(实用本)[J].高血压杂志,2004,12(6):483.
[2] Dennis K E, Aschner J L, Milatovic D. NADPH oxidases and reactive oxygen species at different stages of chronic hypoxia-induced pulmonary hypertension in newborn piglets [J]. Am J Physiol Lung Cell Mol Physiol,2009, 297(4):L596 - 607.
[3] Tsuda K. Roles of adiponectin and oxidative stress in the regulation of membrane microviscosity of red blood cells in hypertensive men-an electron spin resonance study [J]. J Obes, doi: 10.1155/2011/548140.
[4] Halvorsen B,Staff A C,Henriksen T,et al. 8-iso-prostaglandin F(2αlpha) increase expression of LOX-l in JAR cells[J].Hypertension,2001,37(4): 1184-1190.
[5] Santina C, Giuseppe M, Emilio N, et al. Relation of C-Reactive Protein to Oxidative Stress and to Endothelial Activation in Essential Hypertension[J]. Am J Hypertens, 2006, 19: 313-318.
[6] Simic D, Perunicic J,Lasica R,et al. Plasma and red blood cell superoxide dismutase activity in patients with different stages of essential hypertension [J]. Med Arh, 2005, 59(3): 156-159.
[7] Naganuma T, Nakayama T, Sato N, et al. A haplotype-based case-control study examining human extracellular superoxide dismutase gene and essential hypertension [J]. Hypertension Res, 2008, 31(8): 1533-1540.
[8] Kamezaki F, Tasaki H, Yamashita K, et al. Gene transfer of extracellular superoxide dismutase ameliorates pulmonary hypertension in rats [J]. Am J Respir Crit Care Med,2008,177: 219-226.
[9] Ahmed M N, Zhang Y, Codipilly C, et al. Extracellular superoxide dismutase overexpression can reverse the course of hypoxia-induced pulmonary hypertension [J]. Mol Med,2012, 18(1):38-46.
[10] Kelland N F, Bagnall A J, Morecroft I, et al. Endothelial ET B Limits Vascular Remodelling and Development of Pulmonary Hypertension during Hypoxia [J]. J Vasc Res,2010,47(1):16-22.
[11] Shin Y J, Kim J H, Seo J M,et al. Protective effect of clusterin on oxidative stress-induced cell death of human corneal endothelial cells [J]. Molecular Vision,2009, 15:2789-2795.
[12] Amy L. Firth and Jason X. -J. Yuan. Bringing down the ROS: a new therapeutic approach for PPHN [J]. Am J Physiol Lung Cell Mol Physiol,2008, 295(6):L 976-L 978.
Outlines

/